Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis - PubMed (original) (raw)

Review

Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis

Rafeel Syed et al. Biomed Res Int. 2015.

Abstract

Rapidly progressive glomerulonephritis (RPGN) is a syndrome signified by a precipitous loss of renal function, with features of glomerulonephritis including dysmorphic erythrocyturia and glomerular proteinuria. RPGN is associated with extensive crescent formation, and, thus, the clinical term RPGN is often used interchangeably with the pathologic term crescentic glomerulonephritis (CGN). From an immunopathologic standpoint, primary RPGN is divided into pauci-immune GN (PICG), anti-GBM GN, and immune complex GN. PICG, the most common etiology of primary RPGN, refers to a necrotizing glomerulonephritis with few or no immune deposits by immunofluorescence (IF) or electron microscopy (EM). In most patients, pauci-immune CGN is a component of a systemic small vessel vasculitis such as granulomatosis with polyangiitis (GPA). Approximately 90% of patients with PICG have circulating ANCA antibodies, leading to the nomenclature ANCA-associated vasculitis (AAV). Recent research has identified several other antibodies associated with PICG, which is now understood to be a complex spectrum of disease with considerable overlap in terms of clinical phenotype and outcomes. In addition, several genetic and environmental factors have recently been implicated in the pathogenesis of this disorder. With new prognostic classifications, enhanced understanding of immunopathologic mechanisms, and novel treatment paradigms, clinical and experimental interest in PICG remains high.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Cellular crescent.

Figure 2

Figure 2

Fibrinoid necrosis.

Figure 3

Figure 3

Mild tubular atrophy.

Similar articles

Cited by

References

    1. Glassock R. J., Adler S. G., Ward H. J., et al. Primary glomerular diseases. In: Brenner B. M., Rector F. C., editors. The Kidney. 4th. Philadelphia, Pa, USA: Saunders; 1991. pp. 1182–1279.
    1. Charles Jennette J., Falk R. J., McGregor J. G. Comprehensive Clinical Nephrology. 5th. Elsevier; 2015. Renal and systemic valculitis.
    1. Watnick S., Dirkx T. Kidney disease. In: Papadakis M. A., McPhee S. J., Rabow M. W., editors. Current Medical Diagnosis & Treatment 2015. New York, NY, USA: McGraw-Hill; 2014.
    1. Jennette J. C., Olson J. L., Schwartz M. M., Silva F. G. Pauci-immune and ANCA-mediated crescentic glomerulonephritis and vasculitis. Heptinstall's Pathology of the Kidney. (6th) 2007;1(chapter 14)
    1. Seo P., Stone J. H. The antineutrophil cytoplasmic antibody-associated vasculitides. The American Journal of Medicine. 2004;117(1):39–50. doi: 10.1016/j.amjmed.2004.02.030. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources